Symposium Information

Symposium Venue:
Roma Eventi - Fontana di Trevi - Map
Piazza della Pilotta, 4 - 00187 Roma - Italia - P.Iva: 08377041002
Tel: +39 (06) 67015176-5177 Fax: +39 (06) 67015178 

Dates:
December 1-3, 2016

Language:
The official language of the symposium is English. All abstract submissions and presentations will be conducted in English.

Visas:
All participants are required to have a valid passport. Should you need a visa, it is advisable to apply well in advance as they can be time consuming to process. It is the responsibility of the participant to obtain a visa if required. All persons requiring visas, not holding a valid Schengen visa in their travel document, must apply for a visa at the applicable embassy/consulate before travelling to Italy. 

Registration:
The registration desk is located in level (-1) at the Foyer and will be open on
Wednesday, November 30              16:00 - 18:00
Thursday, December 1                   7:30 - 18:00
Friday, December 2                       7:30 - 16:00
Saturday, December 3                   7:30 - 16:00

Symposium Kit and Name Badges:
Upon registration, each attendee will receive a personal kit containing a personal name badge and a program book. Please remember to wear your badge to all symposium activities and to the welcome reception. Please also note that there will be a charge of €30 for re-printing of lost badges.

Internet Service:
Free WIFI is available throughout the symposium in the session halls and exhibition area.
In additionall participants are welcome to use our complementary internet station which will be available at the exhibition area throughout the symposium. Please consider fallow participants when using the facilities.

Exhibition:
All participants are invited to the exhibition area, which will be open throughout the Symposium.

Speakers:
Please submit your PowerPoint slides at the Speakers Ready Room, which will be located in the Leopardi Hall of the Congress Centre (close by to the session Halls, please follow the signage of the Congress), at least one hour before the session begins. Please be so kind and follow the detailed instructions, which were sent to you separately.

Case presentations:
All case presentations will be discussed at the cases bar in the Montale hall over a glass of wine.

e-Posters:
E-posters presentations will be available for viewing throughout the symposium at the exhibition area.  

CME:
Attendance of ISOPT Clinical provides 18 CME credits (ECMEC).

Certificate of Attendance:
A certificate of attendance will be available for all participants at the registration desk starting from Thursday, December 1st, at noon time, and throughout the Symposium.

For assistance during the Symposium, please contact:
Email: Office@ISOPTclinical.com
Tell:  +39 (0)6 67015571

 

Previous Meetings

ISOPT Clinical 12,
Berlin June 9-12, 2015
2015 Final Program

ISOPP 3 Lisbon 1600

ISOPT Clinical 11,
Reykjavik Iceland June 19-22, 2014
2014 Final Program

ISOPP 3 Lisbon 1600

ISOPT Clinical 10,
 Paris March 7-10, 2013

2013 Final Program

ISOPT 10 Paris 2013

ISOPT Clinical 9,
 Vienna December 1-4, 2011 

2011 Final Program

ISOPT 9 Vienna, 2011

ISOPT Asia,
Macau December 9-12, 2010
2010 Final Program

ISOPT Asia Macau, 2010

ISOPT 8,
Rome December 3-6, 2009
2009 Final Program

ISOPT 8 Rome, 1609

ISOPT 7,
 Budapest Feb 28-March 2 2008

2008 Final Program

ISOPP 7 Budapest, 1608

ISOPT 6,
Berlin March 30 – April 2, 2006
2006 Final Program

ISOPT 6 Berlin, 1606

ISOPT 5,
 Monte Carlo March 11-14 2004

2004 Final Program

ISOPP 5 Monte Carlo, 1604

ISOPP 4,
 Seville Feb. 28 - March 3, 2002

2002 Final Program

ISOPP 4 Seville, 1602

ISOPP 3,
Lisbon February 10-13, 2000
2000 Final Program

ISOPP 2 Munich 1997

ISOPP 2,
Munich Sept. 11 - 14, 1997
ISOPP 2, Timetable

ISOPP 2 Munich 1997

ISOPP 1,
Genève Sept 28 - Oct 1, 1995

ISOPP 1, Timetable

 

Industry participants

 

 

 

 

 

                     

                                                                      

 

                            

                                                                

                                        

 

 

 

 

Media Partners

   
   
   
   

Press Releases

 EuroTimes Series sponsored by ISOPT Clinical:

 

 

BEYOND IMAGINATION IN THE FIRST OF A NEW SERIES
OF ARTICLES SPONSORED BY ISOPT CLINICAL,  
BARUCH D KUPPERMANN MD, PHD LOOKS AT THE 
REVOLUTION IN RETINAL PHARMACOLOGY

A decade ago a revolution in the way we treat and
therefore conceive retinal disease took place: the
introduction of anti-VEGF therapy with the concept of
multiple intravitreal injections has completely
transformed wet AMD Read more

 

 

 

CHANGING TIMES IN THIS ARTICLE SPONSORED BY ISOPT CLINICAL, BARRETT KATZ MD, MBA LOOKS A THE EVOLVING NATURE OF THERAPIES FOR OPTIC NEUROPATHIES

It was not so long ago that glaucomatologists and neuro-ophthalmologists lived in different worlds. As our understanding of glaucoma has migrated to appreciate it as, first and foremost, an optic neuropathy, these Read more

   

 

P0INT-OF-CARE TESTS IN A SERIES OF ARTICLES SPONSORED BY ISOPT CLINICAL, PENNY A ASBELL MD, FACS, MBA SAYS POINT-OF-CARE TESTING WILL ALLOW QUICKER, MORE ACCURATE DIAGNOSES

Currently, when we talk about dry eye disease (DED), we typically start with therapy that is the same for all patients – artificial tears, then maybe plugs, topical anti-inflammatories etc. Is this the best approach? Read more...

 

 

 

 

RETINAL IMAGING ISOPT CLINICAL SPONSORED ARTICLE GISÈLE SOUBRANE MD, PHD, FEBO SAYS: "ANALYSIS OF IMAGES BY EXPERIENCED OPHTHALMOLOGISTS IS CRUCIAL"

New imaging can have two meanings – either new information from the recently available imaging systems, or imaging systems resulting from 
new concepts. When fluorescein angiography became popular in the late 1960s, one of the indirect advantages was that ophthalmologists started to collect more documents which markedly improved the quality of the follow-up and thus the knowledge of natural history and treatment results. Read More…

 

 

 

 

DREAM TRIAL ISOPT CLINICAL SPONSORED ARTICLE ASKING WHY ARE WE TALKING ABOUT OMEGA-3 FOR DED TREATMENT? 

The expanding notion in disease today is that inflammation plays a role in nearly all diseases – not just rheumatoid arthritis, but artherosclerotic heart disease too. The peer-reviewed eye literature over the last decade shows increasing evidence of the role of inflammation in dry eye disease (DED)/ocular surface disease, in both animal models and people?(Page 15) Read more...

   

 

 

 Read more about ISOPT Clinical:

   
 Eurotimes  

Diagnostic imaging can reveal new clinical endpoints but validation is required. “I think the industry is the only one who can take on such a burden using a significant number of patients in order to use imaging technology to shorten the time necessary to arrive Read more...

   
 OSN  

Global coordination sought for approval of ophthalmic devices. “Differences between the U.S. and European approval processes have resulted in discussions about the merits of both systems. Dialogue about the variations in approval processes Read more...

   

Useful Links